A Single Dose of 225Ac-RPS-074 Induces a Complete Tumor Response in an LNCaP Xenograft Model-Reference-Cited by-同舟云学术

A Single Dose of 225Ac-RPS-074 Induces a Complete Tumor Response in an LNCaP Xenograft Model

Published:2018-11-09 Issue:5 Volume:60 Page:649-655
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Kelly James M.,Amor-Coarasa Alejandro,Ponnala Shashikanth,Nikolopoulou Anastasia,Williams Clarence,Thiele Nikki A.,Schlyer David,Wilson Justin J.,DiMagno Stephen G.,Babich John W.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference34 articles.

1. Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science;Nussbaum;Prostate Cancer Prostatic Dis.,2016

2. Response and Tolerability of a Single Dose of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis

3. German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

4. PSMA targeted radioligand therapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide: a retrospective analysis of overall survival;Rahbar;Eur J Nucl Med Mol Imaging.,2018

5. [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study;Hoffman;Lancet Oncol.,2018

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors;Nuclear Medicine and Biology;2024-11

2. Effect of Linker Entities on Pharmacokinetics of ¹¹¹In-Labeled Prostate-Specific Membrane Antigen-Targeting Ligands with an Albumin Binder;ACS Pharmacology & Translational Science;2024-07-09

3. Navigating through the coordination preferences of heavy alkaline earth metals: Laying the foundations for 223Ra- and 131/135mBa-based targeted alpha therapy and theranostics of cancer;Journal of Inorganic Biochemistry;2024-07

4. Prostate-specific Membrane Antigen: Alpha-labeled Radiopharmaceuticals;PET Clinics;2024-07

5. Actinium-225 in Targeted Alpha Therapy;Journal of Medical Physics;2024-04